Also written (correctly) as 1,3-di-n-propyl-7-propargylxanthine. A synthetic caffeine analog that is reportedly 100 times more potent than caffeine at both A1 and A2 adensosine receptors. It has not, however, been tested in humans.
Elissa is a former research associate with the University of California at Davis, and the author/co-author of over a dozen articles published in scientific journals. Currently a freelance writer and researcher, Elissa brings her multidisciplinary education and training to her writing on nutrition and supplements.
